Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K C Bible

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Genes & Cancer|June 16, 2012
Antitumor Activity of VB-111, a Novel Antiangiogenic Virotherapeutic, in Thyroid Cancer Xenograft Mouse ModelsH V Reddi, P Madde, Y C Cohen, et al.
Cancer Research|May 16, 2000
Flavopiridol binds to duplex DNAK C Bible, R H Bible, T J Kottke, et al.
Cancer Research|May 19, 2001
Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancerV Shridhar, K C Bible, J Staub, et al.
Cancer Research|February 24, 2001
The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug effluxC Erlichman, S A Boerner, C G Hallgren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridolK C Bible, S A Boerner, K Kirkland, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2013
Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trialR C Smallridge, J A Copland, M S Brose, et al.
The Journal of Biological Chemistry|July 31, 1999
Characterization of caspase processing and activation in HL-60 cell cytosol under cell-free conditions. Nucleotide requirement and inhibitor profileP W Mesner, K C Bible, L M Martins, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Genes & Cancer|June 16, 2012
Antitumor Activity of VB-111, a Novel Antiangiogenic Virotherapeutic, in Thyroid Cancer Xenograft Mouse ModelsH V Reddi, P Madde, Y C Cohen, et al.
Cancer Research|May 16, 2000
Flavopiridol binds to duplex DNAK C Bible, R H Bible, T J Kottke, et al.
Cancer Research|May 19, 2001
Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancerV Shridhar, K C Bible, J Staub, et al.
Cancer Research|February 24, 2001
The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug effluxC Erlichman, S A Boerner, C G Hallgren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridolK C Bible, S A Boerner, K Kirkland, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2013
Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trialR C Smallridge, J A Copland, M S Brose, et al.
The Journal of Biological Chemistry|July 31, 1999
Characterization of caspase processing and activation in HL-60 cell cytosol under cell-free conditions. Nucleotide requirement and inhibitor profileP W Mesner, K C Bible, L M Martins, et al.
Pageof 2